John Overdeck’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

John Overdeck’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,430	Closed	-$5K	–	4115
2019 Q4	$5K	Buy	+11,430	New	+$19K	﹤0.01%	3595
2019 Q2	–	Sell	-34,784	Closed	-$110K	–	3836
2019 Q1	$110K	Buy	+34,784	New	+$113K	﹤0.01%	2890
2018 Q4	–	Sell	-20,823	Closed	-$84K	–	3736
2018 Q3	$84K	Buy	+20,823	New	+$91.8K	﹤0.01%	3088
2014 Q3	–	Sell	-19,104	Closed	-$150K	–	2189
2014 Q2	$150K	Buy	+19,104	New	+$144K	﹤0.01%	2016

Other funds holding CORV

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

John Overdeck's CORV Position: Q1 2020 in Review

John Overdeck sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2020, closing a stake of 11,430 shares — an estimated $5K sold.

John Overdeck first reported a position in CORV in Q2 2014 and held it in 4 quarters. The position peaked at $150K in Q2 2014. 27 funds tracked by Wall St. Rank hold CORV as of Q1 2020.

John Overdeck reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2020 after selling out during the quarter.
John Overdeck sold 11,430 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2020, an estimated $5K.
John Overdeck first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2014 and held it in 4 quarters.
John Overdeck's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $150K in Q2 2014.
27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2020.

Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.